|
Jubilant Pharmova Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
13729.24 Cr.
|
P/BV
|
2.31
|
Book Value (Rs.)
|
372.96
|
|
52 Week High/Low (Rs.)
|
1310/617
|
FV/ML
|
1/1
|
P/E(X)
|
178.07
|
|
Bookclosure
|
02/08/2024
|
EPS (Rs.)
|
4.84
|
Div Yield (%)
|
0.58
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 6644.80 | 6219.30 | 6059.17 | 5963.88 | 5842.84 |
| Other Operating Revenues | 58.10 | 62.43 | 71.00 | 134.66 | 132.95 |
| Total Operating Revenues | 6702.90 | 6281.73 | 6130.16 | 6098.54 | 5975.79 |
| | | | | | |
| Other Income | 68.70 | 38.33 | 11.29 | 17.64 | 37.41 |
| Total Revenue | 6771.60 | 6320.06 | 6141.45 | 6116.17 | 6013.20 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 1821.30 | 1666.41 | 1348.70 | 1348.75 | 1438.02 |
| Purchase Of Stock-In Trade | 241.20 | 252.22 | 201.62 | 167.63 | 154.62 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 78.20 | -40.70 | -62.32 | 19.63 | -137.46 |
| Employee Benefit Expenses | 2216.00 | 2166.02 | 2043.39 | 1922.88 | 1843.22 |
| Finance Costs | 272.30 | 188.20 | 145.49 | 184.10 | 199.71 |
| Depreciation And Amortisation Expenses | 381.90 | 554.03 | 381.70 | 348.95 | 339.84 |
| Other Expenses | 1445.40 | 1461.53 | 1442.44 | 1243.18 | 1129.44 |
| Total Expenses | 6456.30 | 6247.71 | 5501.02 | 5235.12 | 4967.39 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 315.30 | 72.35 | 640.43 | 881.06 | 1045.81 |
| | | | | | |
| Exceptional Items | -168.90 | -56.82 | 0.00 | -21.23 | -32.93 |
| Profit/Loss Before Tax | 146.40 | 15.53 | 640.43 | 859.82 | 1012.88 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 202.60 | 181.09 | 172.55 | 269.91 | 292.11 |
| Deferred Tax | -104.80 | -88.42 | 44.88 | 27.31 | 43.00 |
| Total Tax Expenses | 97.80 | 92.66 | 217.43 | 297.22 | 335.10 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 48.60 | -77.13 | 423.00 | 562.61 | 677.77 |
| | | | | | |
| Profit/Loss From Continuing Operations | 48.60 | -77.13 | 423.00 | 562.61 | 677.77 |
| | | | | | |
| Profit/Loss From Discontinuing Operations | 0.00 | 0.00 | 0.00 | 340.93 | 197.66 |
| Total Tax Expenses Discontinuing Operations | 0.00 | 0.00 | 0.00 | 79.18 | -22.82 |
| Net Profit/Loss From Discontinuing Operations | 0.00 | 0.00 | 0.00 | 261.75 | 220.47 |
| Profit/Loss For The Period | 48.60 | -77.13 | 423.00 | 824.36 | 898.24 |
| | | | | | |
| Minority Interest | 4.40 | 3.90 | 0.92 | 0.26 | 0.00 |
| Share Of Profit/Loss Of Associates | 24.10 | 12.25 | -9.98 | 11.25 | 0.00 |
| Consolidated Profit/Loss After MI And Associates | 77.10 | -60.98 | 413.94 | 835.87 | 898.25 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 4.87 | -3.83 | 26.00 | 52.48 | 56.39 |
| Diluted EPS (Rs.) | 4.86 | -3.83 | 26.00 | 52.48 | 56.39 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 79.60 | 79.64 | 79.64 | 0.00 | 151.32 |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 1.52 |
